Henry Meds payment processor path.

For telehealth and pharmacy platforms in the compounded GLP-1 telehealth category.

Henry Meds is a compounded GLP-1 telehealth platform that scaled significantly during the semaglutide and tirzepatide shortages. Public news has covered their post-de-shortage position and the broader compounded GLP-1 telehealth landscape as the FDA moved on the compounded pathway.

Processor reality for platforms like Henry Meds

Compounded GLP-1 telehealth is the vertical Stripe, Square, and PayPal issued blanket terminations across starting Q1 2025 after the FDA declared the semaglutide shortage resolved February 21, 2025 and tirzepatide December 19, 2024. Direct merchant account placement requires documentation that compounded fulfillment is 503A individualized-prescription with clinical rationale, not bulk 503A.

Direct acquirer placement path

If you operate a compounded GLP-1 telehealth platform in the Henry Meds category, the placement path requires prescriber credentialing packet, 503A pharmacy contracts with individualized-prescription documentation, LegitScript telemedicine certification, and marketing copy review before submission. Clay Pay pre-reviews the packet before it goes to underwriting.

MCC selection

MCC 8011 or 5912 depending on merchant of record; not 5734 or 5967. Aggregator misclassifications (MCC 5734 computer software, MCC 5967 direct marketing) are what trigger post-boarding flags.

LegitScript coordination

LegitScript telemedicine certification required at most acquirers underwriting compounded GLP-1. Certification runs 4 to 8 weeks with a complete packet. Clay Pay coordinates the application in parallel with the merchant account application.

Reserves and Stripe subscription recovery

Typical reserves 8 to 15 percent rolling for compounded GLP-1 with clean documentation. Stripe migration recovery 65 to 80 percent MRR within 30 days on Stripe migration, plus 5 to 10 percent additional in months 2 and 3 via smart retry logic.